Privia Health Group, Inc. · NASDAQ:PRVA

Privia Health — FY2022 Earnings Presentation

20 slides from Privia Health's earnings presentation, Feb 28, 2023

  1. Slide 1: 4th Quarter / Full Year 2022 Results

    4th Quarter / Full Year 2022 Results February 28, 2023 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer 1

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2023 financial guidanc

  3. Slide 3: Agenda

    Agenda ● Key Highlights ● Business Update ● 4Q and Full-Year 2022 Financial Performance ● 2023 Outlook ● Business Update ● Q&A 3

  4. Slide 4: Key Highlights

    Key Highlights Growth and Expansion - Continued High-Level Operating Execution • FY’22 Practice Collections of $2.42B, +49.1% versus FY’21 • FY’22 Adjusted EBITDA of $60.9M, +47.1% versus FY’21 • Strong same-store growth, and solid new provider growth and provider retention • New market entries anno

  5. Slide 5: 4Q'22 Performance

    4Q’22 Performance Implemented Providers (as of end of period) Attributed Lives (‘000s, as of end of period)1 Practice Collections ($mm) 856 786 $634.8 3,606 3,317 500 488 Commercial $513.2 298 355 Government 4Q'21 4Q'22 4Q'21 4Q'22 4Q'21 4Q'22 Care Margin ($mm) Platform Contribution ($mm) Adjusted E

  6. Slide 6: FY'22 Performance

    FY’22 Performance Practice Collections ($mm) Care Margin ($mm) $2,424.1 $305.6 $238.4 $1,626.1 FY'21 FY'22 FY'21 FY'22 Platform Contribution ($mm) Adjusted EBITDA ($mm) $148.5 $60.9 $107.6 $41.4 FY'21 FY'22 FY'21 FY'22 % Practice Collections 6.6% 6.1% % Practice Collections 2.5% 2.5% % Care Margin 4

  7. Slide 7: Strong Balance Sheet and Capital Position

    Strong Balance Sheet and Capital Position ● No debt and ~$348M in net cash ● $65M revolving loan facility available and undrawn as of 12.31.22 (In millions) At 12.31.22 At 12.31.21 Cash and cash equivalents $ 348.0 $ 320.6 Less: Notes payable and debt issuance costs -- $ 33.3 Net cash position $ 348

  8. Slide 8: FY'23 Guidance

    FY’23 Guidance FY’22 Y-Y % Change ($ in millions) FY’23 Guidance Actual from FY’22* Low High Low High Implemented Providers 4,050 4,150 3,606 12.3% 15.1% Attributed Lives 1,050,000 1,150,000 856,000 22.7% 34.3% Practice Collections $ 2,700 $ 2,850 $ 2,424.1 11.4% 17.6% GAAP Revenue $ 1,550 $ 1,650 $

  9. Slide 9: Consistent, Strong Execution Since April 2021 IPO

    Consistent, Strong Execution Since April 2021 IPO • Long-term CAGR Targets: Practice Collections +20% and Adjusted EBITDA +30% FY2020 FY2023 ($ in millions) Actuals FY2021 FY2022 Guidance ‘20-’23 (IPO S-1) Actuals Actuals Midpoint CAGR # of States (actual) 6 8 10 12 26.0% Implemented Providers (end

  10. Slide 10: Building One of the Largest Primary Care-Centric Care Delivery Networks

    Building One of the Largest Primary Care-Centric Care Delivery Networks * Montana 12 950+ 3,606 States Care Center Implemented (plus D.C.) Locations Providers Connecticut (Excludes Privia Care Partners’ providers) California Delaware Ohio Mid-Atlantic 50+ 4M+ 1.1M Tennessee Specialties Patients Attr

  11. Slide 11: Consistent, Replicable Strategy Across all Geographies

    Consistent, Replicable Strategy Across all Geographies Enter Organize Drive Growth & Transition at Scale Market Providers Profitability to Value & Risk  Single-TIN multi-  Community physicians  FFS and VBC  Commercial specialty medical  Health systems practice operations  MSSP group  Same-sto

  12. Slide 12: Diversified Value-Based Platform Across Reimbursement Models

    Diversified Value-Based Platform Across Reimbursement Models 1 1.07 Million 100+ Total Attributed Lives At-Risk Payer Contracts 665K 405K Commercial Government Lives Lives 198K 135K 72K MSSP & Medicare Medicaid MDPCP Advantage Lives Lives Lives % of Lives in Upside / Downside 71% 35% 0% Risk as of 1

  13. Slide 13: Expansion into Connecticut and Delaware

    Expansion into Connecticut and Delaware Acceleration of Privia Care Partners’ Strategy All Other States CT DE Risk-Bearing Entity (CIN / ACO)    ~1,440 Independent / Affiliated Provider Alignment   Privia Care Partners’ Providers Employed / Affiliated Provider Alignment   Option for Providers

  14. Slide 14: PriviaHealth.com/NC

    PriviaHealth. com/NC _ Affiliated with Novant Health Enterprises |

  15. Slide 15: Appendix

    fN Qs APPENDIX

  16. Slide 16: Reconciliation of Operating Income (Loss) to Care Margin

    Reconciliation of Operating Income (Loss) to Care Margin a 1 (1) Care Margin is total revenue less the sum of physician and practice expense. 16

  17. Slide 17: Reconciliation of Operating Income (Loss) to Platform Contribution

    Reconciliation of Operating Income (Loss) to Platform Contribution a 2 (2) Platform Contribution is total revenue less the sum of physician and practice expense and cost of platform. (5) Amount represents stock-based compensation expense included in Cost of Platform. 17

  18. Slide 18: Reconciliation of Net Income (Loss) to Adjusted EBITDA

    Reconciliation of Net Income (Loss) to Adjusted EBITDA a 3 (3) Adjusted EBITDA is net income (loss) attributable to Privia Health Group, Inc. shareholders and subsidiaries excluding minority interests, provision (benefit) for income taxes, interest income, interest expense, depreciation and amortiza

  19. Slide 19: Reconciliation of Net Loss to Adjusted Net Income Per Share

    Reconciliation of Net Loss to Adjusted Net Income Per Share a 19

  20. Slide 20: Thank You

    Thank You PriviaHealth.com Contact: Robert P. Borchert SVP, Investor & Corporate Communications robert.borchert@priviahealth.com Phone: 817.783.4841 20

Privia Health Group — FY2022 Earnings Presentation on 6ix